Home
Dashboard
Curated content
Themes
Innovations
Key Innovators
Key Innovators - Universities
European Innovation Council
Funding rounds
Companies
Corporates
Investors
Jobs
Support Organisations
Events
Investment heatmap
Matching tool
Companies
SK biopharmaceuticals
Save
SK biopharmaceuticals
Developing innovative and next-generation drugs for central nervous system.
Launch date
2011
Employees
201-500 people
Market cap
-
Enterprise valuation
€655—982m
(Dealroom.co estimates Nov 2021.)
Seongnam-si Gyeonggi-do (HQ)
View more
http://skbp.com
https://twitter.com/skbiotek
https://www.linkedin.com/company/sk-biopharmaceuticals
B2B
manufacturing
commission
health
hard tech
biotechnology
biotech and pharma
Overview
Similar companies
Investments (1)
Analytics
Notes
Job openings
Innovations (0)
SK biopharmaceuticals funding
SK biopharmaceuticals investors
Edit
Date
Investors
Amount
Round
Mar 2012
Korea Drug Development Fund
N/A
Seed
Nov 2021
*
Goldman Sachs
KB Investment
Mubadala Capital
WTT Investment
HBM Healthcare Investments
$180m
Series A
Nov 2022
*
Korea Drug Development Fund
N/A
Grant
Total Funding
€164m
Related Content
Recent News about SK biopharmaceuticals
Edit
Investments by SK biopharmaceuticals
Edit
Proteovant Therapeutics
ACQUISITION by SK biopharmaceuticals Jun 2023
